These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 10161611)

  • 41. Drug interaction monitoring program in a community hospital.
    Cramer RL; Sketo DV; Greene JL; Wright CA
    Am J Hosp Pharm; 1992 Mar; 49(3):627-9. PubMed ID: 1598942
    [No Abstract]   [Full Text] [Related]  

  • 42. Treatment of complicated intra-abdominal infections: comparison of the tolerability and safety of intravenous/oral trovafloxacin versus intravenous imipenem/cilastatin switching to oral amoxycillin/clavulanic acid.
    Luke DR; Peterson J
    Int J Clin Pract; 1999; 53(3):166-73. PubMed ID: 10665126
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Patient-teaching service at a university medical center.
    Scott DH; Brown JD; Driesner NK; Lennon JA; Hartzell RS
    Am J Hosp Pharm; 1993 Sep; 50(9):1916-8. PubMed ID: 8135241
    [No Abstract]   [Full Text] [Related]  

  • 44. Peritonsillar abscess: a comparison of outpatient i.m. clindamycin and inpatient i.v. ampicillin/sulbactam following needle aspiration.
    Ozbek C; Aygenc E; Unsal E; Ozdem C
    Ear Nose Throat J; 2005 Jun; 84(6):366-8. PubMed ID: 16075861
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Common bacterial infections and their treatment in hospitalized pediatric patients.
    Fusco NM; Nichols K
    Am J Health Syst Pharm; 2019 Sep; 76(19):1521-1531. PubMed ID: 31532502
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Can extended dosing intervals reduce drug costs while maintaining patient care?
    Tse CS; Madura AJ
    Hosp Formul; 1993 Jul; 28(7):648-50. PubMed ID: 10127047
    [No Abstract]   [Full Text] [Related]  

  • 47. How effective are antibiotic streamlining programs in reducing length of stay and cutting hospital costs?
    Tse CS; Madura AJ; Bates P
    Hosp Formul; 1993 Oct; 28(10):868-70. PubMed ID: 10129136
    [No Abstract]   [Full Text] [Related]  

  • 48. Recombinant human erythropoietin usage in a large academic medical center.
    Bilenker JH; Demers R; Porter DL; Wasserstein AG; Peters E; Manaker S
    Am J Manag Care; 2002 Aug; 8(8):742-7. PubMed ID: 12212761
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A comprehensive system for antimicrobial monitoring and review using a mandatory antimicrobial ordering sheet.
    Jeffrey LP; Mahoney CD
    Hosp Pharm; 1987 Sep; 22(9):877-83. PubMed ID: 10284204
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Developing a drug usage evaluation program.
    Thornton J
    Hosp Formul; 1991 Dec; 26(12):971-2. PubMed ID: 10115411
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Treatment of urinary tract infections among febrile young children with daily intravenous antibiotic therapy at a day treatment center.
    Gauthier M; Chevalier I; Sterescu A; Bergeron S; Brunet S; Taddeo D
    Pediatrics; 2004 Oct; 114(4):e469-76. PubMed ID: 15466073
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Consumption of opioids in a hospital setting--what can we learn from a 10 year follow-up?
    Eisenberg E; Adler R
    Isr Med Assoc J; 2004 Jan; 6(1):19-23. PubMed ID: 14740504
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A pharmacy-based antibiotic UR program.
    Cohen SS
    QRB Qual Rev Bull; 1984 Jan; 10(1):22-5. PubMed ID: 6422381
    [No Abstract]   [Full Text] [Related]  

  • 54. Antibiotic control measures in Dutch secondary care hospitals.
    Schouten JA; Hulscher ME; Natsch S; Grol RP; van der Meer JW
    Neth J Med; 2005 Jan; 63(1):24-30. PubMed ID: 15719849
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Attitudes of housestaff toward a prior-authorization-based antibiotic stewardship program.
    Seemungal IA; Bruno CJ
    Infect Control Hosp Epidemiol; 2012 Apr; 33(4):429-31. PubMed ID: 22418645
    [No Abstract]   [Full Text] [Related]  

  • 56. Pharmacy-laboratory interactions: a unique method to control antibiotic costs.
    Goff D; Thornton J
    Hosp Pharm; 1989 Jan; 24(1):26-9, 32. PubMed ID: 10291600
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A medication use evaluation of alendronate: compliance with administration guidelines.
    Mersfelder T; Armitstead JA; Ivey MF; Cedars M
    Pharm Pract Manag Q; 1999 Jan; 18(4):50-8. PubMed ID: 10339068
    [No Abstract]   [Full Text] [Related]  

  • 58. Drug usage evaluation: clarithromycin as sequential therapy.
    Dempsey CL; Kaley TC; Zenkel J
    Hosp Formul; 1993 Dec; 28(12):999-1001. PubMed ID: 10130382
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Oral antibiotics in the management of serious neonatal bacterial infections in developing country communities.
    Darmstadt GL; Batra M; Zaidi AK
    Pediatr Infect Dis J; 2009 Jan; 28(1 Suppl):S31-6. PubMed ID: 19106761
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pharmacoeconomic decision making: a new type of medication error.
    Dubois RW
    West J Med; 1999 Sep; 171(3):162-3. PubMed ID: 10610601
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.